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Further Questions Regarding the Role of Mosaic penA Sequences in Conferring
Reduced Susceptibility to Ceftriaxone in Neisseria gonorrhoeae
With treatment options for gonorrhea diminishing, the iso-
lation of Neisseria gonorrhoeae strains with reduced suscepti-
bilities to the newer cephalosporins represents a worrying
trend that requires monitoring and investigation. Mutations in
the penA gene encoding the penicillin-binding protein 2
(PBP2) are a major contributor to the emergence of chromo-
somally mediated resistance to -lactam antibiotics in N. gon-
orrhoeae. Recent studies have identified mosaic-like structures
of the PBP2 in clinical isolates of N. gonorrhoeae with de-
creased susceptibilities to both cefixime and ceftriaxone (1, 2,
4, 5). These mosaic sequences are thought to have evolved
from recombination events involving penA gene sequences
from several Neisseria species, including N. perflava, N. sicca,
and N. cinerea (1, 3). Thus, the reduced susceptibility to the
newer cephalosporins is attributed to the acquisition of genetic
material from resistant commensal Neisseria spp. by originally
susceptible gonococci.
We have identified eight clinical isolates of N. gonorrhoeae
harboring mosaic PBP2 sequences as part of an ongoing
study investigating reduced susceptibility to ceftriaxone in
Australian gonococcal isolates (6). DNA sequencing of the
complete penA genes from these isolates revealed that seven
of these strains possessed PBP2 amino acid sequences
(Fig. 1, mosaic A) that were identical to the mosaic PBP2
sequence previously described by Ito et al. (2). All seven
strains had reduced susceptibility to ceftriaxone (MIC 
0.06 mg/liter). The remaining strain possessed a variation of
the mosaic sequence (Fig. 1, mosaic B). Briefly, the first 430
amino acids of the mosaic B sequence in this strain were
nearly identical to the GenBank reference sequence
M32091, except for an additional Asp-345A codon, whereas
the remaining amino acids were similar to those in the
mosaic sequence described by Ito et al. but with three sub-
stitutions. Notably, the strain possessing this variant mosaic
B sequence was fully susceptible to ceftriaxone (MIC
0.008 mg/liter).
FIG. 1. Mosaic PBP2 amino acid sequences identified in the N. gonorrhoeae isolates in this study. The sequences are aligned with a GenBank
N. gonorrhoeae sequence (accession number M32091). The number of isolates with each pattern is indicated in parentheses.
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Takahata et al. recently demonstrated that particular amino
acid substitutions in the mosaic PBP2 (G545S, I312M, V316T)
were responsible for reduced susceptibility to cefixime in Jap-
anese gonococci (4). All three substitutions were present in our
seven strains with the mosaic A sequence but were absent in
the variant mosaic B sequence, suggesting that they may also
have a role in altered ceftriaxone susceptibility. However,
Takahata et al. also found that these substitutions and several
others, although impinging on cefixime MICs, did not greatly
affect ceftriaxone susceptibility (4). This was also shown in
transformation experiments conducted by Takahata et al. in
which full-length mosaic penA sequences conferred only very
minor reductions in ceftriaxone susceptibility to a susceptible
strain and so could not fully explain the reduced susceptibility
of the donor strain (4).
The demonstration that full susceptibility to ceftriaxone is
possible in the presence of this variant mosaic B sequence has
been, thus far, detected only in a single isolate. However, this
finding adds weight to those of Takahata et al. (4) by suggest-
ing that other mosaic-associated mutations located within the
transpeptidase domain have but little impact on ceftriaxone
susceptibility. This brings into question the extent of the con-
tribution of mosaic sequences in conferring reduced suscepti-
bility to ceftriaxone in N. gonorrhoeae. These findings would
need to be confirmed by additional evidence such as the de-
tection of additional ceftriaxone-susceptible gonococci with
mosaic B or similar sequences and adjunctive evidence derived
from transformation experiments. Other mechanisms that may
confer reduced susceptibility to ceftriaxone, including muta-
tions in the ponA (PBP1) gene (5), have been proposed, and
alternatively, as yet undetected second-site mutations may also
be responsible for reversion to the susceptibility patterns re-
ported here. Overall, the data currently available suggest that
the role mosaic penA sequences play in reduced susceptibility
to ceftriaxone, as opposed to cefixime, needs careful and fur-
ther examination.
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